Aerie Pharmaceuticals reported 1.09 in EPS Earnings Per Share for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Aerie Pharmaceuticals AERI:US 1.09 1.81
Alimera Sciences ALIM:US -0.59 0.01
Amarin AMRN:US $ -0.06 0.1
Antares Pharma ATRS:US 0.19 0.16
Bluebird Bio BLUE:US $ -2.14 1.02
Cara Therapeutics CARA:US -0.52 0.11
Coherus Biosciences CHRS:US $ -1 0.54
Endo International Ordinary Shares ENDP:US $ 0.66 0.18
Horizon Pharma HZNP:US $ 1.34 0.07
Insmed INSM:US -0.8 0.15
JAZZ PHA JAZZ:US $ 3.73 0.48
Merk MRK:US $ 2.14 0.34
Mirati Therapeutics MRTX:US -3.4 0.32
Novartis NOVN:VX SF 1.4 0.31
Ophthotech OPHT:US -0.29 0
Pacira Pharmaceuticals PCRX:US $ 0.64 0.33
Regeneron Pharmaceuticals REGN:US $ 11.49 9.83
Revance Therapeutics RVNC:US -0.94 0.01
Supernus Pharmaceuticals SUPN:US 0.29 0.11
Teva Pharmaceutical Industries TEVA:US $ 0.55 0.22
Valeant Pharmaceuticals VRX:CN $ 1.28 0.12
Zoetis ZTS:US $ 1 0.25